Author:
Baker Amanda F,Hanke Neale T,Sands Barbara J,Carbajal Liliana,Anderl Janet L,Garland Linda L
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Zhang J, Wu P, Hu Y: Clinical and marketed proteasome inhibitors for cancer treatment. Curr Med Chem 2013, 20: 2537-2551. 10.2174/09298673113209990122
2. Moore BS, Eustaquio AS, McGlinchey RP: Advances in and applications of proteasome inhibitors. Curr Opin Chem Biol 2008, 12: 434-440. 10.1016/j.cbpa.2008.06.033
3. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R: Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res 2003, 9: 1145-1154.
4. Hoeller D, Dikic I: Targeting the ubiquitin system in cancer therapy. Nature 2009, 458: 438-444. 10.1038/nature07960
5. Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH: Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci U S A 2003, 100: 9946-9951. 10.1073/pnas.1334037100
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献